Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, orthopedic devices giant Stryker
With that in mind, let's take a closer look at Stryker's business and see what CAPS investors are saying about the stock right now.
|Headquarters (Founded)||Kalamazoo, Mich. (1941)|
|Market Cap||$19.5 billion|
|Trailing-12-Month Revenue||$8.1 billion|
|Management||Chairman/CEO Stephen MacMillan
CFO Curt Hartman
|Return on Equity (Average, Past 3 Years)||17.7%|
|Cash/Debt||$3.2 billion / $1.8 billion|
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 98% of the 1,473 members who have rated Stryker believe the stock will outperform the S&P 500 going forward.
Slow and steady wins the race; [Stryker] may not burn any barns, but its positioned to take advantage of a huge long-term trend in the medical field. People are replacing their hips, knees and other joints regularly now with better surgical techniques and longer life-spans, our bodies just were not built for the long-term abuse we subject them to and [Stryker] will rake in profits as long as there are humans on this planet. I've been an avid investor in this company for decades.
But before you run out and start gobbling up shares, some of Stryker's peers might actually be better suited to your own individual investing profile.
Johnson & Johnson
What do you think about Stryker, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!
Want to see how well (or not so well) the stocks in this series are performing? Follow the new TrackPoisedTo CAPS account.